HCA Healthcare (HCA)
(Delayed Data from NYSE)
$397.50 USD
-5.93 (-1.47%)
Updated Sep 17, 2024 04:00 PM ET
After-Market: $397.50 0.00 (0.00%) 7:20 PM ET
1-Strong Buy of 5 1
B Value B Growth F Momentum B VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$397.50 USD
-5.93 (-1.47%)
Updated Sep 17, 2024 04:00 PM ET
After-Market: $397.50 0.00 (0.00%) 7:20 PM ET
1-Strong Buy of 5 1
B Value B Growth F Momentum B VGM
Zacks News
Why Should You Add WellCare Health (WCG) to Your Portfolio?
by Zacks Equity Research
Riding high on a solid revenue base and inorganic growth profile, WellCare Health (WCG) holds high potential to reap benefits for investors.
Why Adding HCA Healthcare to Your Portfolio Makes Sense
by Zacks Equity Research
Riding high on rising revenues and inorganic growth story, HCA Healthcare (HCA) looks promising enough to garner benefits for investors.
Here is Why Growth Investors Should Buy HCA (HCA) Now
by Zacks Equity Research
HCA (HCA) is well positioned to outperform the market, as it exhibits above-average growth in financials.
Looking for Value? Why It Might Be Time to Try HCA Healthcare (HCA)
by Zacks Equity Research
HCA Healthcare (HCA) seems to be a good value pick, as it has decent revenue metrics to back up its earnings, and is seeing solid earnings estimate revisions as well.
Hospital Industry Outlook: Demography, Consolidation Act As Tailwinds
by Sapna Bagaria
Hospital industry to gain from demographical changes and growing consolidation, partially offset by high labor cost.
Solid US Labor Market Puts Focus on 3 Sector ETFs & Stocks
by Sanghamitra Saha
The U.S. labor market has been in great shape defying slowdown worries. Unemployment rate fell to a fresh 49-year low in April. Play this optimism with these sector ETFs and stocks.
The Zacks Analyst Blog Highlights: Pfizer, Intel, HCA Healthcare, Xilinx and Cummins
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Pfizer, Intel, HCA Healthcare, Xilinx and Cummins
3 Reasons Growth Investors Will Love HCA (HCA)
by Zacks Equity Research
HCA (HCA) possesses solid growth attributes, which could help it handily outperform the market.
Top Stock Reports for Pfizer, Intel & HCA Healthcare
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including Pfizer (PFE), Intel (INTC) and HCA Healthcare (HCA).
HCA Healthcare's (HCA) Q1 Earnings Beat Estimates, Up Y/Y
by Zacks Equity Research
HCA Healthcare's (HCA) first-quarter earnings gain traction from higher revenues and better admissions.
HCA Healthcare (HCA) Q1 Earnings and Revenue Beat Estimates
by Zacks Equity Research
HCA Healthcare (HCA) first-quarter earnings gain from solid revenues.
What's in Store for HCA Healthcare's (HCA) Q1 Earnings?
by Zacks Equity Research
HCA Healthcare (HCA) is likely to gain from higher admissions. However, escalating expenses might weigh down its margins.
Earnings Preview: HCA Holdings (HCA) Q1 Earnings Expected to Decline
by Zacks Equity Research
HCA (HCA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Modest Moves in the Big Indexes During the Week, but Still Plenty of Action
by David Borun
The broad markets ended slightly higher during a holiday-shortened week, but two high profile IPOs were the big story
Medicare-for-All, Mueller Report Spell Danger: 5 Utility Picks
by Swarup Gupta
Superior dividend yields and steady revenues make utilities good choices in tough times.
HCA Healthcare's Organic & Inorganic Strategies Drive Growth
by Zacks Equity Research
A number of acquisitions, network expansion, technological investment and strong balance sheet drive growth at HCA Healthcare (HCA).
HCA Healthcare to Buy Large Stake in Galen College of Nursing
by Zacks Equity Research
HCA Healthcare (HCA) to purchase the majority interest in Galen College of Nursing for boosting access to nursing education.
Is HCA Healthcare (HCA) a Worthy Pick for Value Investors?
by Zacks Equity Research
HCA Healthcare (HCA) stock may be a good choice for value-oriented investors right now from multiple angles.
Stock Market News For Mar 7, 2019
by Zacks Equity Research
Benchmarks ended in the red on Wednesday after a slew of weak economic reports weighed on the markets.
Acadia Healthcare (ACHC) Q4 Earnings Miss, Revenues Meet
by Zacks Equity Research
Acadia Healthcare (ACHC) Q4 earnings miss, down year over year on increase in expenses.
Community Health (CYH) Q4 Loss Wider Than Expected, Down Y/Y
by Zacks Equity Research
Community Health's (CYH) Q4 results disappoint with loss from decline in admissions, partially offset by lower expenses.
The Zacks Analyst Blog Highlights: Pepsico, Disney, Sanofi, Diageo and HCA
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Pepsico, Disney, Sanofi, Diageo and HCA
Top Research Reports for Pepsico, Walt Disney & Sanofi
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including Pepsico (PEP), Walt Disney Company (DIS) and Sanofi (SNY).
Cigna's (CI) Q4 Earnings Miss, Revenues Surpass Estimates
by Zacks Equity Research
Cigna's (CI) Q4 earnings miss owing to a rise in expenses, which more than offset the increase in revenues.
Company News For Jan 30, 2019
by Zacks Equity Research
Companies In The News Are: HOG,XRX,PFE,HCA